BioStem Technologies, Inc. SEC filings BSEM
BioStem Technologies, Inc. has 75 filings in SEC EDGAR's recent list, going back to Feb 1, 2016. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (material agreement, unregistered share sale, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Oct 13, 2026 | — |
| EFFECT | Filing | Oct 9, 2026 | — |
| D | Filing | Oct 9, 2026 | — |
| S-8 | Employee stock plan registration | Oct 6, 2026 | — |
| S-1 | Registration statement | Oct 2, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Sep 30, 2026 | Sep 29, 2026 |
| EFFECT | Filing | Sep 29, 2026 | — |
| 424B3 | Prospectus | Sep 29, 2026 | — |
| CORRESP | Letter to the SEC | Sep 25, 2026 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2026 | — |
| D | Filing | Sep 21, 2026 | — |
| S-1 | Registration statement | Sep 18, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Sep 18, 2026 | Sep 18, 2026 |
| 424B3 | Prospectus | Aug 14, 2026 | — |
| 424B3 | Prospectus | Aug 13, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| EFFECT | Filing | Aug 11, 2026 | — |
| S-1/A | Amended registration statement | Aug 7, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 7, 2026 | Aug 6, 2026 |
| SEC STAFF ACTION | Filing | Aug 7, 2026 | — |
| SEC STAFF LETTER | Filing | Aug 6, 2026 | — |
| CERT | Filing | Aug 6, 2026 | — |
| CORRESP | Letter to the SEC | Aug 4, 2026 | — |
| CORRESP | Letter to the SEC | Aug 4, 2026 | — |
| 10-12B/A | Amendment no. 2 form 10-12b | Aug 4, 2026 | — |
| S-1 | Registration statement | Jul 29, 2026 | — |
| CORRESP | Letter to the SEC | Jul 24, 2026 | — |
| 10-12B/A | Amendment no. to 1 form 10-12b | Jul 24, 2026 | — |
| UPLOAD | Letter from the SEC | Jul 22, 2026 | — |
| 10-12G | General form for registration of securities | Jul 10, 2026 | — |
| CORRESP | Letter to the SEC | Jul 9, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2026 | — |
| D | Filing | Jun 3, 2026 | — |
| DRSLTR | Filing | May 28, 2026 | — |
| DRS/A | Filing | May 28, 2026 | — |
| SEC STAFF LETTER | Filing | May 18, 2026 | — |
| UPLOAD | Letter from the SEC | May 18, 2026 | — |
| DRS | Filing | Apr 20, 2026 | — |
| RW | Filing | Oct 28, 2025 | — |
| 10-12B/A | Filing | Jan 23, 2025 | — |
| 10-12B/A | Filing | Nov 27, 2024 | — |
| 10-12B | Filing | Sep 27, 2024 | — |
| D | Filing | Apr 4, 2023 | — |
| D | Filing | May 25, 2021 | — |
| D | Filing | Aug 16, 2016 | — |
| D | Filing | Feb 1, 2016 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BSEM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Pompano Beach, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1658678
- Former names
- BIOSTEM TECHNOLOGIES (until Oct 28, 2025)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.